Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
2
×
life sciences
national blog main
national top stories
new york top stories
san francisco top stories
akcea therapeutics
alnylam pharmaceuticals
barry greene
billy dunn
biogen
boston
boston blog main
boston top stories
boston university
dan ollendorf
drug prices
drug pricing
drugs
europe top stories
evrysdi
gene therapy
genentech
hereditary transthyretin amyloidosis
inotersen
ionis pharmaceuticals
john berk
mary o'donnell
national
new york blog main
novartis
nusinersen
patisiran
regeneron pharmaceuticals
risdiplam
rna drugs
rna interference
roche
What
fda
friday
2
×
medicine
patients
2
×
ago
alnylam
approve
approved
atrophy
awaits
biological
crossed
daily
decades
decision
discovered
drug
evrysdi
fingers
green
historic
home
intended
lights
liquid
muscular
new
oral
risdiplam
rna
roche
spinal
therapy
time
trick
uses
Language
unset
Current search:
friday
×
fda
×
patients
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision